FDA Inspection 1142678 — BioSpectra, Inc.
The FDA completed an inspection of BioSpectra, Inc. on May 4, 2021 in Bangor, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 4, 2021
- Fiscal Year
- 2021
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Bangor, PA (United States)